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ABSTRACT
Introduction: Acute kidney injury is characterized by a rapid loss of renal excretory function with the increase of nitrogen compounds in the 
blood and with different outcome. Objective: Since descriptions of the risk factors and sequelae of acute kidney injury (AKI) remain relatively 
limited, the objective of this study was to determine etiology and clinical characteristics of AKI, as well as risk factors for adverse outcome of renal 
function and death in AKI patients. Methods: We retrospectively studied a cohort of 84 adult AKI patients admitted to Nephrology Clinic in 
University Clinical Centre Sarajevo during period 2012-2014. Demographic, laboratory and clinical parameters were retrieved. The in-hospital and 
6 months mortality were recorded. Renal function outcome was defined 3 months following discharge. Results: Majority of patients were older 
(median age 73.5 years) with great severity of AKI (Stage III in 78.5% of cases) and high burden of comorbidities (mean Charlson comorbidity 
index, CCI score 6.4±3.05). The most common causes of AKI were acute interstitial nephritis (16.7%), heart failure (15.5%), gastroenterocolitis 
(13.1%), and sepsis (12%). Renal function recovery was recorded in 48.8% of patients, with prevalence of 10.7% of intrahospital mortality and 
37.3% of 6 months mortality. Risk factors for poor outcome of renal function and mortality in AKI patients were increasing age and higher CCI 
score, while protective factor was higher diuresis. Sepsis proved to be risk factor for death.
Key words: acute kidney injury, etiology, risk factors, outcome
1. INTRODUCTION
Acute kidney injury (AKI) is increasingly recognized as a 
major contributor to adverse outcomes. The sequelae of AKI 
are severe and characterized by increased risk of short-term and 
long-term mortality, incident chronic kidney disease (CKD) 
and accelerated progression to end-stage renal disease (ESRD) 
(1). The in-hospital mortality rate is approximately 20% to 
50%, and may exceed 75% in critically ill patients or patients 
with sepsis (2).
The rate of renal recovery varies in the literature, possibly 
because of the lack of a consistent definition for renal recovery 
(3-7). Some studies (3, 4) reported that recovery rates ranged 
from 36% to 99%, based on the definition of recovery as dialysis 
independence at discharge. Furthermore, to reduce the severity 
and improve recovery from AKI, it is important to identify the 
underlying cause and risk factors of AKI. Currently, little atten-
tion is given to AKI after it resolves in clinical practice through-
out the healthcare system. Understanding the impact of AKI 
on adverse outcomes may identify a segment of patients during 
hospitalization who are at greater risk of longer-term sequelae.
2. GOAL
The objective of this study was to investigate etiology, clini-
cal characteristics and outcome of AKI patients, as well as to 
identify risk factors for adverse outcome of renal function and 
death in these patients hospitalized in tertiary medical centre.
3. MATERIALS AND METHODS
We retrospectively studied a cohort of 84 adult patients with 
diagnosis of AKI who were admitted to Nephrology Clinic in 
the University Clinical Centre Sarajevo from July, 2012 to June, 
2014. We included all adult patients (>18 years old) with diag-
nosis of AKI and length of hospital stay more than 24 hours. Pa-
tients with ESRD and those who received renal transplantation 
were excluded from the study. This cohort of survived patients 
has been followed up for six months after hospital discharge.
All data were collected from medical files of routine patients 
care in hospital. Demographic informations included age, 
gender and duration of hospital stay. Relevant laboratory tests 
were retrieved. Clinical informations included severity, etiology 
and type of AKI, treatment and outcomes of AKI patients. A 
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standard algorithm proposed by Quan et al. was 
used to defi ne the Charlson comorbidity index 
(CCI) score (5).
AKI was defi ned as an abrupt (within 48 
hours) absolute increase in serum creatinine 
(SCr) of at least 26.5 μmol/L or by a percentage 
increase in SCr ≥50% from baseline according 
to the AKIN criteria (6). Th e severity of AKI 
was defined by the AKIN staging criteria. 
When pre-admission serum creatinine was 
unavailable, it was estimated by the Modifi ca-
tion of Diet in Renal Disease (MDRD) equa-
tion, with the assumption of a near lower limit 
of normal glomerular fi ltration rate (GFR) of 
75 mL/min/1.73 m2, as recommended by the 
Acute Dialysis Quality Initiative (ADQI) 
Working Group (7). AKI was classified as 
prerenal, intrinsic and post renal according to 
the identifi ed etiology. Oliguria was defi ned as 
urine output under 400 mL/day, and anuria as 
urine output under 100 mL/day.
Th e primary outcome of AKI patients was 
in-hospital mortality. Th e outcome of renal 
function was defi ned 3 months following dis-
charge by the values of estimated GFR (eGFR) 
as recovered (eGFR >60 mL/min/1.73 m2) or 
non-recovered (eGFR <60 mL/min/1.73 m2). 
Th is defi nition of renal function outcome re-
fers only to AKI patients without pre-existing 
CKD. AKI patients with underlying CKD were 
considered to have renal function recovery if 
SCr concentrations fell to the baseline 3 months 
aft er discharge. Non-recovery of renal function 
was defi ned if SCr remained above the baseline. 
Th e secondary outcome was 6 months mortality. 
Th e patients alive 6 months aft er discharge were 
classifi ed as „survivors“, and those who died as 
„non-survivors“.
Statistical analysis
Normally distributed continuous variables 
were reported as means with standard deviations 
and compared by Student’s t-test. Non-normally 
distributed continuous data were reported as 
medians with interquartile ranges and compared 
using Mann-Whitney U-test. When outcome 
variable was binary or categorical, proportion 
between two or more groups was assessed by 
Chi-square test or Fischer’s exact test when there 
were sparse data. P values less than 0.05 were 
considered statistically signifi cant.
4. RESULTS
A total number of 84 AKI patients (41 females and 43 males) 
with mean age of 73,5 years met inclusion criteria. Demo-
graphic, laboratory and clinical characteristics of patients have 
been shown in Table 1. Great proportion of AKI patients were 
non-oliguric (79.8%), while anuria and oliguria were present 
in 7.1% and 13.1% of AKI patients, respectively. Among the 
cohort of 84 AKI patients, 6% cases were classifi ed as Stage I, 
15.5% cases as Stage II, and 78.5% cases as Stage III. Prerenal 
and intrinsic type of AKI were similarly represented (45.2% 
and 42.8%, respectively), while post renal type of AKI proved 
to be less frequent (12%).
Prevalence of comorbid diseases was 77.4%. Th e most com-
mon comorbid conditions were hypertension (35.7%), diabetes 
mellitus (28.6%), congestive heart failure (16.6%), chronic liver 
disease (13.1%) and cancer (11.9%), with average CCI values 
6.4±3.05. Pre-existing CKD was present in 45.2% of AKI pa-
tients. Conservative treatment was far more frequent than renal 
Characteristics                                                                               Values
Male (n, %)                                                        43 (51.2)
Age (years) 73.5 (64-82)
Length of hospital stay (days) 16.5 (10-23)
Scr levels (μmol/L) at admission and at discharge 446 (304-616)/139.5 (99.5-227)
eGFR 3 months aft er discharge 42 (20.5-60.4)
Diuresis 
Anuria (n, %) 6 (7.1)
Oliguria (n, %) 11 (13.1)
Diuresis >400 mL (n, %) 67 (79.8)
AKIN Stage
Stage I (n, %) 5 (6)
Stage II (n, %) 13 (15.5)
Stage III (n, %) 66 (78.5)
Type of AKI
Prerenal (n, %) 38 (45.2)
Intrinsic (n, %) 36 (42.8)
Postrenal (n, %) 10 (12)
Pre-existing CKD Yes/No (n, %) 38 (45.2)/46 (54.8)
Hypertension Yes/No (n, %) 30 (35.7%)/54 (64.3%)
Diabetes mellitus Yes/No (n, %) 24 (28.6%)/60 (71.4%)
CCI score 6.4±3.05
Treatment RRT/Conservative (n, %) 18 (21.4)/66 (78.6)
Renal function recovery Yes/No (n, %) 41 (48.8%)/43 (51.2%)
Intra-hospital mortality Yes/No (n, %) 9 (10.7%)/75 (89.3%)
6-month mortality Yes/No (n, %) 28 (37.3%)/47 (62.7%)
Total mortality Yes/No (n, %) 38 (45.2%)/46 (54.8%)
Table 1. Characteristics of patients with acute kidney injury. Data are presented as median 
and interquartile range or as means and standard deviation (SD); n – number; SCr–serum 
creatinine; eGFR–estimated glomerular fi ltration rate; AKIN–Acute Kidney International 
Network; AKI–acute kidney injury; CKD–chronic kidney disease; CCI–Charlson comorbidity 
index; RRT – renal replacement therapy
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replacement therapy (RRT) (78.6% vs. 
21.4%). Renal function recovery was 
present in 48.8% of AKI patients 3 
months after discharge. Total mortality 
rate was 45.2%, with presence of 10.7% 
of intrahospital deaths and 37.3% of 
deaths 6 months after discharge.
Etiology of AKI in cohort of 84 
patients has been presented in Figure 
1. The most common causes of AKI 
were acute interstitial nephritis (AIN) 
in 16.7%, acute decompensated heart 
failure (ADHF) in 15.5%, acute gastro-
enterocolitis (13.1%), and sepsis (12%), 
while the remaining etiologies partici-
pated with less than 10.5%.
The comparison between prevalence 
of the most common AKI causes ac-
cording renal function outcome and 
survival is shown in Table 2. Only septic etiology of AKI has 
demonstrated statistically significant higher prevalence in 
deaths compared to survivors (p=0.004).
Greater proportion of AKI patients without pre-existing 
CKD has recovered renal function (Figure 2) in comparison 
to those AKI patients who had presumed CKD (60.53% vs. 
43.48%; p=0.120). The presence of presumed CKD in AKI 
patients seemed to have influence on mortality since greater 
proportion of AKI patients without CKD survived in compari-
son to those who had underlying CKD (60.87% vs 47.37%), but 
without statistically significant difference (p=0.216).
By univariate analysis (Table 3), risk factors for poor outcome 
of renal function in AKI patients were older age (p=0.009) and 
higher CCI (p=0.000). Protective factor for renal function 
recovery was higher diuresis (p=0.010). However, risk factors 
for mortality were increasing age (p=0.0001), higher CCI 
(p=0.000) and diagnosis of sepsis (p=0.015), while higher di-
uresis (p=0.047) proved to be a protective factor for mortality.
5. DISCUSSION
Of the 84 AKI patients in our study group, majority of pa-
tients were over 70 years of age (mean age 73.5 years) and the 
most of them were males (51.2%). This is not unexpected since 
epidemiological data confirm that the median age of patients 
suffering from AKI is increasing. Male gender is also known 
to be associated with AKI probably due to more frequent vas-
cular diseases (8).
Majority of patients in our study were classified as Stage 
III (78.5%) according to AKIN criteria. Cases of AKI in our 
referral center were mainly associated with CKD (45.2%) with 
rapid decline in kidney function, which could be explanation for 
the high prevalence of Stage III in our study. This is consistent 
with findings of other authors who found a higher prevalence 
of Stage III in Division of Nephrology in comparison with 
other Departments of Internal Medicine (2). In our study group 
prerenal and intrinsic type were detected in 45.2% and 42.8% 
of AKI patients, respectively, while post renal type of AKI was 
recognized only in 12% of patients. The prevalence of intrinsic 
causes was similar to the occurrence of renal causes in the study 
of Yang et al. (2) while post renal AKI was less frequent.
The main etiological factors of AKI in the present study 
were AIN (16.7%), ADHF (15.5%), acute gastroenterocolitis 
(13.1%), and sepsis (12%), followed by severe dehydration (8%), 
obstructive nephropathy due to the genitourinary cancer (6%) 
and ATN (6%), with other etiologies prevalence less than 5%. 
In the PICARD study and BEST Kidney study (9, 10) heart 
failure and sepsis were among four most common AKI causes 
which is consistent to our findings. Some authors used extended 
definitions of renal hypo perfusion (11). Similarly, if we use an 
extended definition of renal hypo perfusion that includes heart 
failure and volume depletion due to the gastroenterocolitis and 
dehydration, prevalence of renal hypo perfusion in our study 
increases to 36%, which is consistent with the results of Nash 
et al. (11).
Presence of preexisting CKD was rather high in our study 
group (45.2%). High proportion of AKI patients suffered 
from CKD (51%) was found in the study of Pereira et al. too 
(12). Almost 77.4% of our patients had some kind of comorbid 
condition. In accordance with recent reports (12), our results 
confirmed that the most common comorbidities were hyper-
tension (35.7%) and diabetes mellitus (28.6%), followed by 
congestive heart failure (16.6%), chronic liver disease (13.1%) 
and cancer (11.9%).
Dialysis was carried out in 21.4% of our AKI patients, which 
is consistent with the proportion of AKI patients who received 
RRT (22.5%) in the study of Yang et al. (2). Dialysis require-
ment in different studies ranged from 12% to 71% (2,13,14).
Recognition that AKI survivors are at high risk of progres-
AKI etiology
(n, %)
Renal func-
tion recovery
Renal function 
non-recovery p-value Survivors
Non-
survivors p-value
AIN 14 (16.7) 9 (64.3) 5 (35.7) 0.283 6 (42.9) 8 (57.1) 0.327
ADHF 13 (15.5) 4 (30.8) 9(69.2) 0.096 9(69.2) 4 (30.8) 0.202
Enterocolitis 11(13.1) 7 (63.6) 4 (36.4) 0.521 9 (69.2) 4 (30.8) 0.1
Sepsis 10 (12) 3 (30) 7 (70) 0.19 1 (10) 9 (90) 0.004*
Table 2. The prevalence of the most common acute kidney injury causes according renal function outcome 
and survival. *p <0.05; AKI–acute kidney injury; AIN–acute interstitial nephritis; ADHF–acute 
decompensated heart failure
Dependent variable Renal function recovery Mortality
Variables OR p-value 95% CI OR p-value 95% CI
Age 0.95 0.009* 0.92 - 0.98 1.07 0.0001* 1.03 - 1.12
Diuresis 3.89 0.01* 1.37 - 11.04 0.43 0.047* 0.18 - 0.98
CCI score 0.71 0.000* 0.58 - 0 .84 2.61 0.000* 1.75 - 3.87
Sepsis 0.36 0.166 0.08 - 1.51 13.96 0.015* 1.67 - 116.12
Table 3. Univariate analysis for risk factors for renal function outcome and mortality in acute kidney injury 
patients *p <0.05; OR – odds ratio; CI–confidence interval; CCI–Charlson comorbidity index
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sive CKD spurred the Kidney Disease Improving Global Out-
comes (KDIGO) AKI guidelines to recommend that the kidney 
function should be evaluated 3 months after an AKI episode to 
establish the presence and extent of CKD (15), which was done 
in our study. Renal function recovery was established in 48.8% 
of cases, which is similar to proportion of patients with renal 
function recovery in the studies of Pereira and Yang with their 
associates (50% and 58.6%, respectively) (2, 12). Nevertheless, 
evaluation of kidney function in these studies was done at hospi-
tal discharge that might be too soon due to mentioned KDIGO 
AKI guidelines (15). Furthermore, definition of renal function 
recovery was different in all three mentioned studies (included 
ours), indicating a need for standardization of this definition.
AKI is associated with short and long-term mortality. 
Undoubtedly, this patient population has a poor short-term 
outcome with excessive in-hospital morality rates (40-60%) 
(16). Total mortality in our cohort group of patients increased 
from 10.7% at discharge to 45.2% after 6 months of follow up. 
In-hospital mortality in the study of Schiffl et al. (16) increased 
from 47% at discharge to 65% after 1 year of follow up. All AKI 
patients included in the study of Schiffl et al. had ATN as cause 
of AKI, RIFLE class Failure and they all underwent RRT. This 
might be the reason why the in-hospital mortality rate is higher 
compared to our results. A large Danish study (17) has shown 
that mortality was the most important during the first 50 days 
after admission to ICU. Our results have also shown great in-
crease of mortality for AKI survivors after 6 months of follow 
up, which can be related to great severity of AKI with high bur-
den of comorbid conditions and rather older age of study group.
The previous conventional opinion that survivors of AKI 
tend to do well and fully recover renal function appears to be 
flawed. AKI can cause ESRD directly, and increase the risk of 
developing incident CKD and worsening of underlying CKD 
(18). In accordance with previous reports (19,20), we have also 
found that greater proportion of AKI patients with pre-existing 
CKD had impaired recovery of renal function in comparison to 
the patients with „pure“ AKI (56.52% vs. 39.47%), but without 
statistically importance. Presence of CKD is also known to be 
a significant risk factor for the development of cardiovascular 
diseases from which this CKD population of patients often 
dies (12). However, our results showed that presence of pre-
sumed CKD was similar in the survivors and non-survivors 
groups (47.36% vs. 52.63%) which is consistent with published 
researches (12, 20). 
Our findings revealed that risk factors for non-recovery of 
renal function were advanced age and higher CCI, while pro-
tective factor for renal function outcome was higher diuresis. 
Other authors identified older age, the presence of diabetes 
mellitus, decreased baseline eGFR (21), or higher CCI score 
(22) as risk factors for the progression to advanced-stage CKD 
in AKI survivors which is similar to our results. The risk factors 
for mortality in present study were diagnosis of sepsis as well 
as increasing age and higher CCI score, while protective factor 
was higher diuresis. In the previously published studies (8,14) 
sepsis and oliguria were found to be associated with mortality 
which is in accordance with our findings. Similarly to our find-
ings, Harel et al. (22). found that increasing age and higher CCI 
were predictive of post-AKI mortality.
Sepsis is the most common cause of AKI in ICU (14). Recent 
evidence suggests that AKI in patients with sepsis may have 
different pathophysiology including hyperemia, vasodilatation, 
and acute tubular apoptosis instead of ischemia, vasoconstric-
tion, or acute tubular necrosis (23). The mortality of sepsis 
induced AKI is more than 70% (14). Our findings suggest that 
septic cause of AKI is statistically significantly more common 
in non-survivors compared to survivors, as well as that sepsis is 
risk factor for death in AKI patients.
6. CONCLUSION
Elderly patients with high burden of comorbidities who 
experience severe AKI episode and especially those with sepsis 
as AKI etiology are with high risk for adverse outcome of renal 
function and death. These observations highlight the impor-
tance of close monitoring high-risk hospital AKI patients. The 
CCI score is a validated method for estimating the risk of death 
from comorbid disease but it also seemed to be a good tool in 
predicting adverse renal function outcome.
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Editorial 
Public health aspects of nephrology, dialysis and kidney transplantation in Bosnia and 
Herzegovina 
It is my great pleasure to introduce to you this special issue of the journal Materia Socio-
Medica on the occasion of the 4th Congress of Nephrology of Bosnia and Herzegovina with 
international participation that will be held in Sarajevo from 22nd to 25th April 2015. The 
Association of Nephrology, Dialysis and Transplantation of Bosnia and Herzegovina has 
organized congress under the auspices of the European Renal Association – European 
Dialysis and Transplant Association (ERA-EDTA) and the International Society of 
Nephrology (ISN). 
This scientific meeting covers the most recent discoveries in the fields of acute kidney injury, 
chronic kidney disease, cardiovascular diseases, hypertension, diabetes mellitus, dialysis and 
kidney transplantation. Gathering a large number of national and international nephrologists 
as well as many distinguished international speakers will certainly contribute to the 
knowledge transferring and quality of this meeting. There will be (ubaciti broj) submitted 
presentations from (broj zemalja koje učestvuju) countries. 
Rapid increases in the incidence of acute kidney injury have been reported, highlighting a 
growing contribution to the public health burden of advanced kidney disease. The sequelae of 
acute kidney injury are severe and characterized by increased risk of short-term and long-term 
mortality, incident chronic kidney disease and accelerated progression to end-stage renal 
disease. Contributors to the growth of acute kidney injury include increases in the known 
precipitants of acute kidney injury such as sepsis, congestive heart failure, higher age and 
comorbidity burden of patients. Identification of the underlying cause and risk factors of acute 
kidney injury is needed in order to reduce the severity and improve recovery of this harmful, 
but preventable and treatable syndrome. Protecting the kidneys from acute kidney injury 
should be an important health strategy for the patient and the community.  
Chronic kidney disease is serious public health problem that is characterized by poor health 
outcomes and very high health-care costs. Furthermore, chronic kidney disease is a major risk 
multiplier in patients with diabetes, hypertension, heart disease and stroke—all of which are 
key causes of death and disability. Since the prevalence of chronic kidney disease is higher in 
older people, the health impact of population aging will depend in part on how the kidney 
